(1R,2S)-VU0155041
CAS: 1263273-14-8
Ref. 3D-NAC27314
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
(1R,2S)-VU0155041 is a low-potency glutamate receptor antagonist that has been shown to have neuroprotective effects. It prevents neuronal death by blocking the excitatory function of glutamate receptors. This compound also has antioxidative properties and can prevent oxidative injury in cells by inhibiting the production of reactive oxygen species. (1R,2S)-VU0155041 may be useful as a pharmacological treatment for diseases associated with glutamate imbalance, such as Parkinson's disease or Huntington's disease. The compound has been found to have no effect on locomotor activity in rats and displays low affinity at the mglur4 receptor. In addition, it exhibits potential as a drug target for several neurological disorders and may be used to treat stroke, Alzheimer’s disease, and other disorders associated with oxidative injury.
